Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study was designed to compare the pharmacokinetics of Prograf and Advagraf in stable
pediatric kidney transplant recipients.
Enrolled patients on prograf will have pharmacokinetic study of tacrolimus for 24 hours and
after that, the same dose of advagraf will be prescribed. The patients will have another
pharmacokinetic study of tacrolimus after conversion to advagraf.